EMA Refused: Solumarv (Insulin human) — Marvel Lifesciences Ltd

View source ↗

Summary

The EMA refused the MAH's marketing authorization application for Solumarv (insulin human) by Marvel Lifesciences Ltd for diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Solumarv (human insulin)

Snippet

Status: Refused. Therapeutic area: Diabetes Mellitus. MAH: Marvel Lifesciences Ltd. Decision date: 11/02/2016